Dry Age Related Macular Degeneration Clinical Trial
Official title:
Open-Label, Single-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of SCNT-hES-RPE Cells in Patients With Advanced Dry AMD
To evaluate the safety and tolerability of human somatic cell nuclear transfer embryonic stem cell derived retinal pigmented epithelial(SCNT-hES-RPE) cellular therapy in patients with advanced dry AMD
To evaluate the safety and tolerability of the SCNT-hES-RPEs, to assess the number of SCNT-hES-RPE cells to be transplanted in future studies and to evaluate on an exploratory basis potential efficacy endpoints to be used in future studies of SCNT-hES-RPE cellular therapy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01674829 -
A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD
|
Phase 1/Phase 2 | |
| Completed |
NCT00751361 -
Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial
|
Phase 4 | |
| Completed |
NCT01344993 -
Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration
|
Phase 1/Phase 2 | |
| Completed |
NCT00804102 -
Transcorneal Electrical Stimulation Therapy for Retinal Disease
|
N/A | |
| Suspended |
NCT00541333 -
Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration
|
Phase 1 | |
| Completed |
NCT00429936 -
Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
|
Phase 2 |